J. Christopher Love

J. Christopher Love serves as the Raymond A. (1921) and Helen E. St. Laurent Professor of Chemical Engineering at MIT's Koch Institute for Integrative Cancer Research. His distinguished career began with a B.S. in Chemistry from the University of Virginia and a Ph.D. in Physical Chemistry from Harvard University under George Whitesides. After completing postdoctoral research in immunology at Harvard Medical School with Hidde Ploegh and the Immune Disease Institute, Love has established himself as a leading researcher combining chemical engineering, interfacial chemistry, and materials science to develop innovative micro- and nanotechnologies. His laboratory focuses on advancing therapeutic discovery, particularly in areas such as cancer, HIV/AIDS, multiple sclerosis, Type 1 diabetes, and food allergies. Love has garnered numerous prestigious accolades, including the W.M. Keck Distinguished Young Scholar for Medical Research, Dana Scholar for Human Immunology, and was named one of Popular Science's Brilliant 10. He has co-founded several biotechnology companies, including OneCyte Biotechnologies, HoneyComb Biotechnologies, and Sunflower Therapeutics, while also serving as a scientific advisor to companies like Repligen and Alloy Therapeutics. His research has resulted in over 100 manuscripts and multiple patents in single-cell analysis and biomanufacturing, demonstrating his significant impact on the field.